MTM Investment Management LLC Sells 113 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

MTM Investment Management LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 896 shares of the healthcare conglomerate’s stock after selling 113 shares during the quarter. MTM Investment Management LLC’s holdings in UnitedHealth Group were worth $453,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Hemington Wealth Management increased its position in UnitedHealth Group by 5.9% in the fourth quarter. Hemington Wealth Management now owns 1,126 shares of the healthcare conglomerate’s stock worth $569,000 after buying an additional 63 shares in the last quarter. Ingalls & Snyder LLC boosted its position in shares of UnitedHealth Group by 1.7% in the fourth quarter. Ingalls & Snyder LLC now owns 8,670 shares of the healthcare conglomerate’s stock worth $4,386,000 after purchasing an additional 143 shares during the period. McClarren Financial Advisors Inc. raised its position in shares of UnitedHealth Group by 62.7% during the 4th quarter. McClarren Financial Advisors Inc. now owns 1,533 shares of the healthcare conglomerate’s stock valued at $775,000 after purchasing an additional 591 shares during the period. Hidden Cove Wealth Management LLC bought a new position in UnitedHealth Group in the 4th quarter worth $214,000. Finally, Naples Global Advisors LLC lifted its position in shares of UnitedHealth Group by 3.0% in the fourth quarter. Naples Global Advisors LLC now owns 14,468 shares of the healthcare conglomerate’s stock valued at $7,319,000 after acquiring an additional 428 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.2 %

NYSE UNH opened at $527.31 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company’s 50-day simple moving average is $526.25 and its two-hundred day simple moving average is $563.96. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market capitalization of $485.27 billion, a price-to-earnings ratio of 34.02, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the firm posted $5.83 earnings per share. The business’s quarterly revenue was up 6.8% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research analyst reports. UBS Group lowered their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Piper Sandler decreased their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Finally, Bank of America decreased their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.